文献速递瓣膜外科

瓣膜类型是否影响自体瓣膜心内膜炎术后感染性心内膜炎复发?倾向加权比较

Can prosthesis type influence the recurrence of infective endocarditis after surgery for native valve endocarditis? A propensity weighted comparison.
PubMed 文献 · Eur J Cardiothorac Surg · 2021-01-01

本研究纳入395例因左侧自体瓣膜心内膜炎行瓣膜置换的患者(机械瓣314例,生物瓣81例),采用逆概率治疗加权比较长期无复发、无再手术生存率。结果显示机械瓣与生物瓣在复发和再手术方面无显著差异,但机械瓣长期生存更优,尤其在主动脉瓣位置。

要点

  • 机械瓣与生物瓣在感染性心内膜炎复发和再手术风险上无显著差异
  • 机械瓣长期生存优于生物瓣,30年生存率34.9% vs 10.5%
  • 主动脉瓣亚组中机械瓣生存优势更明显(41.6% vs 10.1%)

核心结论

  • 分析显示机械瓣作为自体瓣膜心内膜炎的瓣膜替代物有临床获益趋势,尤其在主动脉瓣位置。
  • 鉴于长期无不良事件生存,瓣膜类型选择应根据患者特征和具体临床情况个体化。

研究设计与样本

  • 回顾性队列研究,纳入395例因左侧自体瓣膜心内膜炎行瓣膜置换的患者(机械瓣314例,生物瓣81例)。
  • 排除标准包括年龄<18岁、再次手术、人工瓣膜心内膜炎、右心瓣膜受累、瓣膜修复和同种移植物植入。
  • 采用逆概率治疗加权(IPTW)平衡两组基线特征。

主要发现

  • IPTW后,感染性心内膜炎无复发率机械瓣84.1±3.2% vs 生物瓣50.6±21.7%,P=0.29。
  • 无再手术率机械瓣85.7±3.1% vs 生物瓣50.9±21.9%,P=0.29。
  • 排除竞争死亡后,生物瓣与机械瓣相比复发subdistribution HR 1.631(95%CI 0.756-3.516,P=0.21),再手术IPTW-HR 1.737(95%CI 0.780-3.870,P=0.18)。
  • 机械瓣与长期生存改善相关(30年生存率34.9±5.8% vs 10.5±7.4%,P=0.0009),主动脉瓣亚组41.6±9.3% vs 10.1±8.2%,P<0.0001。
  • 心血管死亡风险两种瓣膜类型无差异(IPTW:HR 1.361,95%CI 0.771-2.404,P=0.29)。

临床怎么用

  • 对于左侧自体瓣膜心内膜炎需瓣膜置换的患者,机械瓣在长期生存方面可能更优,尤其主动脉瓣位置。
  • 瓣膜类型选择应综合考虑患者特征和具体临床情况,而非仅基于复发风险。

局限性

  • 原文未明确报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Our goal was to investigate whether the incidence of valve-related adverse events might be different depending on the valve substitute after valve replacement for left-sided native valve endocarditis. METHODS: We assessed the long-term freedom from recurrence, reoperation and survival of 395 patients who had valve replacements for native valve endocarditis (314 mechanical vs 81 biological). Age <18 years, reoperation, prosthetic endocarditis, right valve involvement, valve repair and homograft implants were the main exclusion criteria. The balance between the 2 groups was addressed by weighting the results on the inverse of the propensity score. RESULTS: After inverse probability of treatment weighting (IPTW), freedom from recurrence of infective endocarditis was not significantly different (mechanical 84.1 ± 3.2% vs 50.6 ± 21.7%; P = 0.29) nor was freedom from reoperation different (mechanical 85.7 ± 3.1% vs biological 50.9 ± 21.9%; P = 0.29). Excluding competing deaths, patients receiving a bioprosthesis had a similar subdistribution hazard of the above end points compared to recipients of a mechanical valve [recurrence IPTW: hazard ratio (HR) 1.631, 95% confidence interval (CI) 0.756-3.516; P = 0.21; reoperation IPTW-HR 1.737, 95% CI 0.780-3.870; P = 0.18]. Mechanical valves were associated with improved long-term survival (34.9 ± 5.8% vs 10.5 ± 7.4% at 30 years; P = 0.0009; in particular: aortic valve subgroup 41.6 ± 9.3% vs 10.1 ± 8.2%; P < 0.0001), although the hazard of cardiovascular mortality did not favour either valve type (IPTW: HR 1.361, 95% CI 0.771-2.404; P = 0.29). CONCLUSIONS: Our analysis showed a clinical trend in favour of mechanical valves as valve substitutes for native valve endocarditis, especially in the aortic position. In view of long-term freedom from adverse events, the choice of the valve type should be tailored according to patient characteristics and specific clinical conditions.

来源:Eur J Cardiothorac Surg,查看原文。版权归原作者所有。

引用

  1. Rubino AS, Della Ratta EE, Galbiati D, et al. Can prosthesis type influence the recurrence of infective endocarditis after surgery for native valve endocarditis? A propensity weighted comparison. Eur J Cardiothorac Surg. 2021. PMID: 34008022. doi:10.1093/ejcts/ezab238

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。